After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...
A Midtown-based medical device startup is carving a niche in the growing field of treatments to address chronic lung disease.
But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.
Therapies to treat IPF are limited ... and cellular interactions in distinct cell populations in chronic obstructive pulmonary disease ...
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...
Study AER-01-002 is using a novel and precision imaging strategy to enroll 100 mucus plug-high chronic obstructive pulmonary disease (COPD ... company developing novel inhaled treatments for ...